Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_assertion type Assertion NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_head.
- NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_assertion wasGeneratedBy ECO_0000203 NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_provenance.
- NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_assertion wasDerivedFrom befree-2016 NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_provenance.
- NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_assertion SIO_000772 15118125 NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_provenance.
- NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_assertion evidence source_evidence_literature NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_provenance.
- NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_assertion description "[EGFR mutations were found in additional lung cancer samples from U.S. patients who responded to gefitinib therapy and in a lung adenocarcinoma cell line that was hypersensitive to growth inhibition by gefitinib, but not in gefitinib-insensitive tumors or cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442101.RAaG_4YYnGUViF0_XdDy2k8jIdd3aWuTQRx75q0xeNdEo130_provenance.